The India precision medicine market was valued at USD 2.68 Billion in 2025, driven by increasing adoption of genomics-based diagnostics and rising government support for personalized healthcare initiatives across the region. The market is anticipated to grow at a CAGR of 11.80% during the forecast period of 2026-2035, with the values likely to reach USD 8.18 Billion by 2035. The market benefits from expanding healthcare infrastructure and growing demand for targeted therapies. Advancements in AI-driven analytics and the integration of electronic health records are expected to boost adoption in the forecast period, contributing to improved patient outcomes and enhanced treatment efficacy.
Base Year
Historical Period
Forecast Period
According to the World Health Organization (WHO), rising cases of infectious diseases like the Zika virus in India, with 151 reported cases in 2024, are driving demand for targeted therapies, accelerating growth in the precision medicine market.
In April 2025, Fortis Healthcare launched the Fortis Institute of Genomic Medicine, advancing precision medicine through genomics and AI integration. This innovation is expected to significantly accelerate India’s precision medicine market growth by enabling personalized therapies.
The India precision medicine market is rapidly growing, driven by rising chronic diseases, increased genomic research, and government support. Trends like personalized therapies and AI integration are accelerating market expansion and improving patient outcomes.
Compound Annual Growth Rate
11.8%
Value in USD Billion
2026-2035
*this image is indicative*
Precision medicine is an advanced medical approach that tailors treatment and prevention strategies to individual genetic, environmental, and lifestyle factors. It aims to improve patient outcomes by providing more accurate diagnoses and targeted therapies based on personal variability. The precision medicine market in India is experiencing significant growth due to increasing healthcare digitization, rising chronic disease prevalence, and advancements in genomics and data analytics. Government initiatives and growing investments in biotechnology further support market expansion. The market is poised to grow at a CAGR of 11.80% during the forecast period of 2026–2035, driven by evolving clinical practices and the adoption of personalized healthcare solutions.
Increasing Prevalence of Cancer to Elevate the Market Growth
The rising prevalence of cancer is emerging as a highly significant growth driver in the precision medicine market in India. According to the Indian Council of Medical Research (ICMR), it was estimated that over 1.4 million new cancer cases were diagnosed across India in 2023 alone. This rising cancer burden is driving strong demand for personalized and targeted therapies that enhance treatment efficacy and reduce adverse effects. As a result, the adoption of precision medicine is accelerating across the country, thereby fueling substantial and continuous expansion of the market.
Key trends in the market include the increasing adoption of gene therapy and the formation of strategic genomic collaborations.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Segmentation Based on Application to Witness Substantial Growth
Precision medicines have a wide range of applications across various medical fields, including oncology, neurology, immunology, hematology, respiratory diseases, and others. According to the Indian Council of Medical Research (ICMR), India recorded over 14 lakh new cancer cases in 2023, underscoring the urgent need for targeted treatments. This significant cancer burden positions oncology as the leading application segment within the precision medicine market. The increasing adoption of personalized therapies, driven by advances in genetic testing and molecular diagnostics, further supports oncology’s dominance. Although other segments, such as neurology and immunology, are growing steadily, oncology is expected to remain the primary driver of market growth in India.
The precision medicine market report in India covers North India, East and Central India, West India, and South India. Among these, South India is expected to lead due to its robust healthcare infrastructure and progressive medical initiatives. For instance, in April 2025, SunAct Cancer Institute and Smita Memorial Hospital launched a CAR T-Cell Therapy Centre in Kerala, emphasizing precision oncology, pediatric care, and international clinical trials. This development underscores South India's growing role in advancing affordable, cutting-edge cell and gene therapies.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Strand Life Sciences, established in 2000 and headquartered in Bangalore, India, is a life sciences technology company specializing in bioinformatics, diagnostics, and clinical research. In April 2024, it entered a strategic partnership with SOPHiA GENETICS to advance precision medicine. The collaboration aimed to integrate Strand’s bioinformatics platforms and curated variant databases with the SOPHiA DDM Platform to enhance genomic analysis and support data-driven healthcare decisions, particularly benefiting patient outcomes in India.
Established in 2012 and headquartered in Hyderabad, MapmyGenome India Ltd., is a key player in the India precision medicine market. The company specializes in personal genomics and preventive health solutions. Its product, Cardiomap, exemplifies its focus on cardiovascular health by assessing genetic predisposition to heart conditions. MapmyGenome integrates genetic insights with lifestyle data to support personalized prevention strategies, advancing precision medicine in India.
Redcliffe Labs is actively contributing to the India precision medicine market through innovative diagnostic solutions. It was established in 2018 and is headquartered in Noida, India. In May 2025, the company launched Femcliffe, India’s first women-centric diagnostic platform. Femcliffe offers tailored diagnostic packages across all stages of a woman’s life, addressing conditions like PCOS, reproductive disorders, and metabolic diseases, with services available nationwide.
Headquartered in Basel, Switzerland, and founded in 1996, Novartis AG is actively engaged in the precision medicine market. The company offers extensive educational and digital resources aimed at enhancing biomarker testing and personalized therapies, particularly in oncology and hematology. Through initiatives such as molecular diagnostics in personalized cancer care and essential elements of biomarker testing, Novartis supports healthcare professionals in delivering targeted, individualized treatments aligned with precision medicine principles.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include MedGenome Labs, CORE Diagnostics, Positive Bioscience, Neuberg Diagnostics, Leucine Rich Bio, Sarepta Therapeutics, Inc., and GSK plc.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share